WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present - PubMed (original) (raw)
WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present
A G Mosser et al. J Virol. 1993 Mar.
Abstract
Twenty-two spontaneous mutants of the Sabin strain of poliovirus type 3 were selected for drug resistance by plating on HeLa cell monolayers in the presence of WIN 51711, an uncoating inhibitor. When replated in the presence and absence of drug, two classes of mutants were observed; mutants displayed either a drug-dependent or a non-drug-dependent phenotype, in the proportion 14:8. Non-drug-dependent mutants plaqued with equal efficiency in the presence or absence of drug. By contrast, drug-dependent mutants made no plaques in the absence of drug, except for revertants. In single-step growth curve experiments, however, drug-dependent mutants grew as well in the absence of drug as in its presence. This paradoxical behavior of dependent mutants was traced to extreme thermolability at 37 degrees C (12- to 30-s half-life) in the absence of drug. Thermolability was exhibited only after the virus was released from the cell, implying the presence of a cell-associated protective factor, possibly pocket factor. Thus, in the absence of a thermostabilizing drug, drug-dependent mutants decayed too rapidly after release to permit spread in the plaque assay. The thermodecay product was shown to consist of 135S particles lacking VP4.
Similar articles
- Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.
Mosser AG, Shepard DA, Rueckert RR. Mosser AG, et al. Arch Virol Suppl. 1994;9:111-9. doi: 10.1007/978-3-7091-9326-6_12. Arch Virol Suppl. 1994. PMID: 8032243 - Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
Mosser AG, Sgro JY, Rueckert RR. Mosser AG, et al. J Virol. 1994 Dec;68(12):8193-201. doi: 10.1128/JVI.68.12.8193-8201.1994. J Virol. 1994. PMID: 7966611 Free PMC article. - Isolation and biological characterization of 3(2H)-isoflavene-resistant and -dependent poliovirus type 2 Sabin mutants.
Genovese D, Catone S, Farah ME, Gambacorta A, Fiore L. Genovese D, et al. J Gen Virol. 1999 Jan;80 ( Pt 1):157-167. doi: 10.1099/0022-1317-80-1-157. J Gen Virol. 1999. PMID: 9934698 - Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
Fox MP, Otto MJ, McKinlay MA. Fox MP, et al. Antimicrob Agents Chemother. 1986 Jul;30(1):110-6. doi: 10.1128/AAC.30.1.110. Antimicrob Agents Chemother. 1986. PMID: 3019232 Free PMC article. - A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.
Rombaut B, Andries K, Boeyé A. Rombaut B, et al. J Gen Virol. 1991 Sep;72 ( Pt 9):2153-7. doi: 10.1099/0022-1317-72-9-2153. J Gen Virol. 1991. PMID: 1716654
Cited by
- Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
Strauss M, Filman DJ, Belnap DM, Cheng N, Noel RT, Hogle JM. Strauss M, et al. J Virol. 2015 Apr;89(8):4143-57. doi: 10.1128/JVI.03101-14. Epub 2015 Jan 28. J Virol. 2015. PMID: 25631086 Free PMC article. - Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus.
Salvati AL, De Dominicis A, Tait S, Canitano A, Lahm A, Fiore L. Salvati AL, et al. Antimicrob Agents Chemother. 2004 Jun;48(6):2233-43. doi: 10.1128/AAC.48.6.2233-2243.2004. Antimicrob Agents Chemother. 2004. PMID: 15155227 Free PMC article. - Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.
Couderc T, Delpeyroux F, Le Blay H, Blondel B. Couderc T, et al. J Virol. 1996 Jan;70(1):305-12. doi: 10.1128/JVI.70.1.305-312.1996. J Virol. 1996. PMID: 8523541 Free PMC article. - Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.
Belnap DM, Filman DJ, Trus BL, Cheng N, Booy FP, Conway JF, Curry S, Hiremath CN, Tsang SK, Steven AC, Hogle JM. Belnap DM, et al. J Virol. 2000 Feb;74(3):1342-54. doi: 10.1128/jvi.74.3.1342-1354.2000. J Virol. 2000. PMID: 10627545 Free PMC article. - An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW, Racaniello VR. Dove AW, et al. J Virol. 2000 Apr;74(8):3929-31. doi: 10.1128/jvi.74.8.3929-3931.2000. J Virol. 2000. PMID: 10729171 Free PMC article.
References
- Nature. 1985 Sep 12-18;317(6033):145-53 - PubMed
- Antimicrob Agents Chemother. 1985 Jun;27(6):883-6 - PubMed
- J Antimicrob Chemother. 1985 Sep;16(3):284-6 - PubMed
- Science. 1986 Sep 19;233(4770):1286-93 - PubMed
- Antimicrob Agents Chemother. 1986 Jul;30(1):110-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous